eRegister's captcha

Supplementary Protection Certificate Details

Print page icon Print this page

Supplementary Protection Certificate (SPC) Summary
SPC No. 2019/010
Date of filing 20/02/2019
Notification of Application Published 20/03/2019
Status Rejected
Notification of Grant Published
Date of Expiry of SPC
Applicant ARRAY BIOPHARMA INC.
3200 Walnut Street
Boulder
Colorado 80301
UNITED STATES OF AMERICA
Patent Number 2727918
Title of Invention Compounds and Compositions as Protein Kinase Inhibitors
Date of Expiry of Patent 26/08/2030
Product Type Medicinal Product
Product Identity Combination of binimetinib and encorafenib, each in all forms protected by the basic patent
Market AuthorisationIreland European Union 
Authorisation NoEU/1/18/1315  EU/1/18/1314 
Authorisation Date24/09/2018 24/09/2018 
Identity of Product AuthorisedMEKTOVI(Binimetinib) BRAFTOVI(encorafenib) 
Market AuthorisationIreland European Union 
Authorisation NoEU/1/18/1314  EU/1/18/1315 
Authorisation Date24/09/2018 24/09/2018 
Identity of Product AuthorisedBRAFTOVI(encorafenib) MEKTOVI(Binimetinib) 
Address for Service HANNA MOORE + CURLEY
Garryard House
25/26 Earlsfort Terrace
Dublin 2
D02 PX51
IRELAND
Renewal Fees
01/03/2019 Request for grant a Supplementary Protection Certificate filed on 20/02/2019, numbered 2019/010.
28/01/2021 Request for grant of Supplementary Protection Certification No. 2019/010 rejected in respect of Article 10(2) of Regulation (EC) No. 469/2009
24/03/2021 Written grounds of decision issued on 12 March 2021.